Home » Topics » Regulatory » Patents

Patents
RSS

Shionogi & Co. divulges MGAT2 inhibitors

May 15, 2017

Boehringer Ingelheim discovers plasma kallikrein inhibitors

May 15, 2017

Trillium Therapeutics identifies novel fluorinated heterocycle derivatives

May 15, 2017

Hua Medicine patents metabotropic glutamate mGlu5 receptor antagonists

May 15, 2017

Esteve presents sigma 1 receptor ligands

May 15, 2017

Jiangsu Nhwa, Wuhan Jiayu patent dopamine and serotonin receptor ligands

May 12, 2017

Beijing Konruns Pharmaceutical Technology identifies novel PDE4 inhibitors

May 12, 2017

NSAID derivatives patented by ratiopharm

May 11, 2017

Jortan Pharmaceuticals discovers beta-secretase 2 inhibitors

May 11, 2017

Universite de Montreal discloses novel proteinase-activated receptor 4 antagonists

May 10, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...